June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
ZO-1 and Na/K ATPase are expressed in a human-engineered corneal endothelium
Author Affiliations & Notes
  • Maria Dolores Montalvo Parra
    Tecnologico de Monterrey (ITESM), Monterrey, NUEVO LEON, Mexico
  • Judith Zavala
    Tecnologico de Monterrey (ITESM), Monterrey, NUEVO LEON, Mexico
  • Manuel Chacon
    Instituto Oftalmológico Fernandez-Vega, Oviedo, Asturias, Spain
  • Natalia Vazquez
    Instituto Oftalmológico Fernandez-Vega, Oviedo, Asturias, Spain
  • Alvaro Meana
    Instituto Oftalmológico Fernandez-Vega, Oviedo, Asturias, Spain
  • Jesus Merayo-Lloves
    Instituto Oftalmológico Fernandez-Vega, Oviedo, Asturias, Spain
  • Jorge E Valdez
    Tecnologico de Monterrey (ITESM), Monterrey, NUEVO LEON, Mexico
  • Footnotes
    Commercial Relationships   Maria Dolores Montalvo Parra, None; Judith Zavala, None; Manuel Chacon, None; Natalia Vazquez, None; Alvaro Meana, None; Jesus Merayo-Lloves, None; Jorge Valdez, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1204. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Dolores Montalvo Parra, Judith Zavala, Manuel Chacon, Natalia Vazquez, Alvaro Meana, Jesus Merayo-Lloves, Jorge E Valdez; ZO-1 and Na/K ATPase are expressed in a human-engineered corneal endothelium. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1204.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corneal engineering is a potential tool to address the donor shortage. The main challenges in this matter are the expression of functional molecular markers and cellular morphology, which are mediated by the use of a proper scaffold. In this study, we analyzed the expression and location of ZO-1 and Na/K ATPase of an engineered corneal endothelium (ECE).

Methods : Corneoscleral rings from corneas previously used for PK were obtained from the local Eye Bank and Instituto Oftalmológico Fernández-Vega, according to the Declaration of Helsinki. Rings were placed in maintenance medium Optisol/Eusol-C at 4°C. Tissues were processed within two days. The remaining CE of seven corneoscleral rings was dissected. Isolated CE was placed overnight at 37°C in a culture plate with culture media (OptiMEM-I, 8% FBS, 20 ng/ml of nerve growth factor, 5 ng/ml of epidermal growth factor, 200 mg/l of calcium chloride, 0.3 mM ascorbic acid, 0.04% chondroitin sulfate, and 1% antibiotics). Then, CE rings were digested with collagenase Type I. Obtained hCECs were cultured on 48 well plates until 90% confluence. ECE were made out of hCECs adhered to the collagen scaffold we produced: a 1:1 passage was made to transfer CECs onto an 8 mm diameter collagen scaffold until confluence. Then, constructs were fixed and co-immunocytochemistry detection of ZO-1 and Na/K ATPase markers was carried out. Uncultured human corneal endothelium rings were used as controls. Photodocumentation and 3D analysis were made using wide-field epifluorescence microscopy.

Results : CE from 7 PK-remaining corneoscleral rings produced 4 ECE. Co-expression of Na/K ATPase and, ZO-1 was observed in all ECE and in control CE. The normal complex 3D morphology of CE with the basal podocyte-like configuration and flattened-hexagonal-perimeter apical side is appreciated at the ECE. The basolateral location of Na/K ATPase is seen as a wavy-frilly skirt around the basal perimeter and, ZO-1 as the typical zig-zag distribution between cells of the apical side.

Conclusions : The use of PK-residual CE opens the possibility of producing two CE from a single organ donor cornea: these options must be further explored in order to optimize. Our collagen-based scaffold serves as hCECs carrier. Moreover, our ECE presents hexagonallity and molecular expression of ZO-1 and ATPase, making it suitable for potential use in translational research.

This is a 2020 ARVO Annual Meeting abstract.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×